Form 8-K - Current report:
SEC Accession No. 0001140361-25-000870
Filing Date
2025-01-13
Accepted
2025-01-13 07:05:29
Documents
15
Period of Report
2025-01-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20041448_8k.htm   iXBRL 8-K 29145
2 EXHIBIT 99.1 ef20041448_ex99-1.htm EX-99.1 26050
6 image00001.jpg GRAPHIC 4485
  Complete submission text file 0001140361-25-000870.txt   204188

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA adma-20250113.xsd EX-101.SCH 3998
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20250113_lab.xml EX-101.LAB 21967
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20250113_pre.xml EX-101.PRE 16055
17 EXTRACTED XBRL INSTANCE DOCUMENT ef20041448_8k_htm.xml XML 4030
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 25524762
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)